Inventor · disambiguated record
Simiao Lin
Also filed as: LIN SIMIAO
4 granted patents·4 pending applications·6 citations·filing 2015–2024
60Inventor score
Files withSHENZHEN IN VIVO BIOMEDICINE TECH LIMITED COMPANY3GUANGZHOU REFORGENE MEDICINE CO LTD2ZHAOTAI IMMUGENE BIOMEDICINE HONG KONG LTD2GUANGDONG ZHAOTAI INVIVO BIOMEDICINE CO LTD1
Top patents by PatentIndex Score
8 records- 0177US10093717B2Chimeric antigen receptor containing a toll-like receptor intracellular domainSHENZHEN IN VIVO BIOMEDICINE TECH LIMITED COMPANY·Filed 2015·Granted Oct 9, 2018·6 cites·13 claims
- 0269US12497617B2SnRNA targeting USH2A pre-mRNA and application thereofGUANGZHOU REFORGENE MEDICINE CO LTD·Filed 2024·Granted Dec 16, 2025·0 cites·11 claims
- 0362US2024392291A1Nucleotide and use thereofGUANGZHOU REFORGENE MEDICINE CO LTD·Filed 2024·Application pending·0 cites
- 0446US2022185858A1Genetically modified immune cell, preparation method therefor, and applicationSHENZHEN IN VIVO BIOMEDICINE TECH LIMITED COMPANY·Filed 2020·Application pending·0 cites
- 0545US2022325246A1Engineered human immune cells, preparation method and application thereofZHAOTAI IMMUGENE BIOMEDICINE HONG KONG LTD·Filed 2020·Application pending·0 cites
- 0644US12502405B2Chimeric antigen receptor for recognizing Fc fragment and application thereofSHENZHEN IN VIVO BIOMEDICINE TECH LIMITED COMPANY·Filed 2020·Granted Dec 23, 2025·0 cites·21 claims
- 0742US2023055186A1Engineered immune killer cell, preparation method therefor and use thereofZHAOTAI IMMUGENE BIOMEDICINE HONG KONG LTD·Filed 2020·Application pending·0 cites
- 0836US11713348B2ScFv amino acid sequence, chimeric antigen receptor containing same and application thereofGUANGDONG ZHAOTAI INVIVO BIOMEDICINE CO LTD·Filed 2019·Granted Aug 1, 2023·0 cites·14 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →